Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Health insurers, including Cigna, Humana and Elevance Health, are tucking changes to DEI strategies and business risks into ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Elevance Health in a report released on Thursday, February 27th. Zacks Research analyst K. Dey now forecasts that the ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with ... such as public health epidemics and pandemics, and other ...

Julie Utterback is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers life sciences firms in the healthcare industry.Utterback ...

“They continue to report, year-over-year ... it will continue using data-driven insights to simplify health care. Yet Elevance is subject to pressures far beyond Wall Street.

See if the 14 Elevance Health analysts we track are forecasting continued growth with our free report on analyst estimates for the company. If you are a dividend investor, you might also want to ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor ...